Reletter
Artwork for Ad Cistulam

Ad Cistulam

Xeftis

Litterae Latinae (et aliae) multimodis, a litteris ipsis ad peripheriam.

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues18Founded4 years agoLast Issue2 years ago
Active
Language
Catalan

Read this Newsletter

adcistulam.substack.com
Artwork for Ad Cistulam

Latest Issues

Quare "superbia" recte dicatur de mense illo festivo deque rebus ad homosexualitatem pertinentibus.

Revertitur quoque anno cum Phoebo fervido simul eadem quaestio, quo nomine illae pompae Latine nominandae sint, quas vulgus pride vocat. Nam omnes Latinistas, quicumque sunt, erunt et fuerunt, laudare et extollere volumus: nemo est quin Lat...

2 years ago
5

Mors est hodie adversus me.

Tertia querimonia viri (130-142)

Hujus querimoniae animadvertite collationes : odores, velata scapha, nubes… Id eam conectit cum ceteris querimoniis et orationibus.

« Mors est hodie adversus me ;

sicut vir aeger convalescens,

sicut fora...

2 years ago
2

Cui hodie loquar?

Prima viri querimonia (85-103)

Sequuntur quattuor querimoniae in quibus primus versus semper recinitur.

Os aperui ad meum animum,

ut ad ejus dicta responderem.

« Vide : putet meum nomen1 ;

vide, plus quam currus odor

die messis2, cale...

2 years ago
2

Bonum sequere diem, pone curas.

Subscribe now

Animi tertia oratio (55-68)

Aperuit suum os meus animus

ut ad dicta mea responderet :

« Quod de sepultura mones, miseria1 est ;

Afferre est lacrimas virum contristando,

Arripere est virum suae domo ut in colli relictus s...

2 years ago
5

Vir non es.

Ignoscite mihi quod haec pars morata vestris e-pistolis advenit. Meam memoriam interdum labascere non mentiar.

Subscribe now

[Vir loquitur pro animo]

Quae mihi dixit animus1 :

« Vir non es ;

An vivis tu quidem2 ? Quid tibi lucro,

si i...

2 years ago
5

Key Facts

Contact Information
Newsletter Author
Number of Subscribers
Find out how many people subscribe to this newsletter.

Audience Metrics

Subscribers, engagement, traffic and sponsorship for Ad Cistulam.

SubscribersMonthly Web VisitsAccepts Sponsors
Estimated Cost per Ad

Authors

The writers behind this newsletter.

  • Xeftis

    Salvete! Studens sum atque de quibuslibet rebus scriptito.

  • Frequently Asked Questions

    How can I access the email archive for Ad Cistulam?

    You can find recent issues that have been published by Ad Cistulam on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does Ad Cistulam have?

    To see how many people subscribe to Ad Cistulam, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in Ad Cistulam?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch Ad Cistulam as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like Ad Cistulam?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact Ad Cistulam using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters related to Ad Cistulam?

    Scroll up to where it says Related Newsletters to see other publications like Ad Cistulam. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact Ad Cistulam?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.